ロード中...
Beyond anti-VEGF: dual-targeting antiangiogenic and antiproliferative therapy
Antiangiogenesis is a promising antitumor strategy that inhibits tumor vascular formation to suppress tumor growth. Specifically, targeting VEGF has shown therapeutic benefits in many cancer types, leading to its approval as the first antiangiogenic drug by the Food and Drug Administration in the Un...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
e-Century Publishing Corporation
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3665913/ https://ncbi.nlm.nih.gov/pubmed/23724163 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|